Available
Specifications
Manufacturer: MSD International GmbH (Puerto Rico Branch), LLC
Active ingredient: Suvorexant
Shelf life: It is recommended to read the information on the packaging or in the official instructions for the drug.
Current price
$272
Place an order
Want to find several options? Our manager will clarify all the details of your order and choose a convenient delivery option
Delivery and self-delivery
Storage conditions
It is recommended to store in a cool, dry place, protected from light and out of reach of children.
Belsomra
Belsomra (active ingredient: suvorexant) is a medication designed for the treatment of insomnia, characterized by difficulty initiating or maintaining sleep.
Indications for Use:
- Treatment of insomnia in adult patients.
Contraindications:
- Severe hepatic impairment.
- Narcolepsy or cataplexy.
- Concurrent use with strong inhibitors of the CYP3A enzyme.
- Concurrent use with other medications indicated for insomnia.
- Pregnancy and breastfeeding (use only if prescribed by a healthcare professional, considering potential benefits and risks).
- Pediatric patients under 18 years of age.
- Known hypersensitivity to suvorexant or any components of the formulation.
Side Effects:
- Headache.
- Somnolence (excessive drowsiness).
- Dizziness.
- Diarrhea.
- Xerostomia (dry mouth).
- Vivid or unusual dreams.
Precautions:
Before initiating treatment with Belsomra, consultation with a healthcare provider is essential to determine the appropriate dosage and assess potential risks. This medication should be used under the supervision of a medical professional.
Film-coated tablets, 20 mg of active substance.
